// App-Quantinova.ai

: First steps at implementing value based healthcare internationally in sarcoidosis: comparing outcomes

Researchers

Presenter

  • Nynke Kampstra

Principal Investigators

  • Philip J van der Wees

  • Paul B Van der Nat

  • Frouke van Beek

  • Coline HM van Moorsel

  • Robert P Baughman

  • Daniel C Culver

  • Elizabeth A Renzoni

  • Vasilis Kouranos

  • Wim Wuyts

  • Marlies S Wijsenbeek

  • Pieter Zanen

  • Jan C Grutters

Medical Centers

  • Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, the Netherlands and Radboudumc, Scientific Center for Quality of Healthcare (IQ Healthcare), Nijmegen, the Netherlands, Nieuwegein, Netherlands

  • Radboudumc, Scientific Center for Quality of Healthcare (IQ Healthcare), Nijmegen, the Netherlands, Nijmegen, Netherlands

  • Department of advisors to the Board of Directors, St. Antonius Hospital, Nieuwegein, The Netherlands, Nieuwegein, Netherlands

  • Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St. Antonius Hospital, Nieuwegein, Netherlands,

  • Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, the Netherlands and Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands, Nieuwegein, Netherlands

  • Division of Pulmonary and Critical Care Medicine, University of Cincinnati Hospitals, Cincinnati, USA, Cincinnati, United States of America

  • Department of Pulmonary, Allergy and Critical Care Medicine, The Cleveland Clinic Foundation, Cleveland, USA, Cleveland, United States of America

  • National Heart & Lung Institute, Imperial College London, Royal Brompton Hospital, London, United Kingdom

  • Royal Brompton Hospital, London, England, United Kingdom

  • Unit for Interstitial Lung Diseases, Department of Respiratory Medicine, University Hospitals Leuven, Leuven, Belgium,

  • Department of Hepatology, Erasmus MC, University Medical Center Rotterdam, the Netherlands, Rotterdam, Netherlands

  • Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital, Nieuwegein, the Netherlands and Division of Heart and Lungs, University Medical Centre Utrecht, Utrecht, The Netherlands, Nieuwegein, Netherlands

Locations

  • Netherlands

  • United States

  • United Kingdom

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Interstitial lung disease

  • Sarcoidosis

Biomarkers

  • Pore forming protein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved